Showing results (231-240 of 306) with videos related to
Sort By:
Pageof 31
Bone Marrow Transplantation|October 1, 1993
Autologous bone marrow transplantation for acute lymphoblastic leukemiaK Doney, C D Buckner, L Fisher, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 1984
Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionationH J Deeg, N Flournoy, K M Sullivan, et al.Bone Marrow Transplantation|January 1, 1989
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantationR S Hill, P Mazza, D Amos, et al.The New England Journal of Medicine|January 26, 1989
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphomaC Anasetti, D Amos, P G Beatty, et al.Bone Marrow Transplantation|April 1, 1999
Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CYC H Weaver, L S Schwartzberg, B Zhen, et al.Vox Sanguinis|January 1, 1983
Transfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemiaJ C Wulff, T J Santner, R Storb, et al.Bone Marrow Transplantation|June 30, 1998
High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cellsC H Weaver, T Moss, L S Schwartzberg, et al.Bone Marrow Transplantation|December 24, 1997
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinomaC H Weaver, F A Greco, J D Hainsworth, et al.The New England Journal of Medicine|March 30, 1989
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasmsK M Sullivan, R Storb, C D Buckner, et al.Bone Marrow Transplantation|January 1, 1991
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancyJ Nemunaitis, J W Singer, C D Buckner, et al.Pageof 31